D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Broadcom
AVGO
|
+$596M |
| 2 |
Accenture
ACN
|
+$470M |
| 3 |
Intel
INTC
|
+$412M |
| 4 |
Adobe
ADBE
|
+$365M |
| 5 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$258M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$1.5B |
| 2 |
Apple
AAPL
|
+$1.02B |
| 3 |
Microsoft
MSFT
|
+$776M |
| 4 |
Netflix
NFLX
|
+$688M |
| 5 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$542M |
Sector Composition
| 1 | Technology | 26.84% |
| 2 | Consumer Discretionary | 15.19% |
| 3 | Financials | 10.39% |
| 4 | Healthcare | 9.6% |
| 5 | Industrials | 6.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2076
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.09B
| $944K | ﹤0.01% |
+8,324
| New | +$944K |
|
2077
InvenTrust Properties
IVT
$2.33B
| $940K | ﹤0.01% |
+37,971
| New | +$940K |
|
2078
CBIZ
CBZ
$3.01B
| $932K | ﹤0.01% |
12,581
-6,843
| -35% | -$507K |
|
2079
Utz Brands
UTZ
$1.12B
| $926K | ﹤0.01% |
55,662
+45,232
| +434% | +$753K |
|
2080
SentinelOne
S
$6.13B
| $925K | ﹤0.01% |
43,944
+13,108
| +43% | +$276K |
|
2081
ASGN Inc
ASGN
$2.25B
| $923K | ﹤0.01% |
+10,471
| New | +$923K |
|
2082
TriCo Bancshares
TCBK
$1.48B
| $919K | ﹤0.01% |
23,218
+6,071
| +35% | +$240K |
|
2083
Raymond James Financial
RJF
$33.9B
| $914K | ﹤0.01% |
+7,396
| New | +$914K |
|
2084
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.6B
| $912K | ﹤0.01% |
+9,486
| New | +$912K |
|
2085
4D Molecular Therapeutics
FDMT
$318M
| $912K | ﹤0.01% |
43,426
-322
| -0.7% | -$6.76K |
|
2086
Mizuho Financial
MFG
$82.3B
| $911K | ﹤0.01% |
215,326
-302,942
| -58% | -$1.28M |
|
2087
Dave & Buster's
PLAY
$818M
| $909K | ﹤0.01% |
22,830
-6,598
| -22% | -$263K |
|
2088
Telefônica Brasil
VIV
$20B
| $909K | ﹤0.01% |
+110,699
| New | +$909K |
|
|
BRSP
2089
BrightSpire Capital
BRSP
$764M
| $908K | ﹤0.01% |
159,217
+73,425
| +86% | +$419K |
|
|
IGMS
2090
DELISTED
IGM Biosciences
IGMS
| $900K | ﹤0.01% |
131,065
+37,902
| +41% | +$260K |
|
2091
Oppenheimer Holdings
OPY
$805M
| $900K | ﹤0.01% |
18,789
+4,558
| +32% | +$218K |
|
2092
Entravision Communication
EVC
$226M
| $900K | ﹤0.01% |
443,162
+122,884
| +38% | +$249K |
|
2093
Northwest Bancshares
NWBI
$1.83B
| $896K | ﹤0.01% |
+77,547
| New | +$896K |
|
2094
Vertex
VERX
$3.84B
| $894K | ﹤0.01% |
24,793
-183,874
| -88% | -$6.63M |
|
2095
Innospec
IOSP
$2.06B
| $893K | ﹤0.01% |
7,223
-754
| -9% | -$93.2K |
|
2096
Sprinklr
CXM
$1.88B
| $890K | ﹤0.01% |
92,482
-36,660
| -28% | -$353K |
|
2097
Royalty Pharma
RPRX
$15.7B
| $886K | ﹤0.01% |
+33,612
| New | +$886K |
|
2098
Amicus Therapeutics
FOLD
$2.47B
| $886K | ﹤0.01% |
89,275
-35,751
| -29% | -$355K |
|
2099
Scansource
SCSC
$973M
| $878K | ﹤0.01% |
19,805
+12,064
| +156% | +$535K |
|
2100
Praxis Precision Medicines
PRAX
$794M
| $872K | ﹤0.01% |
+21,077
| New | +$872K |
|